but credit due where she grew sales in the direct channel as a rapid turn around from the 3M debacle. In the next 6 months this effort will be proven to be more beneficial or if it’s a smoke and mirrors tricks. I think the comment she made at an investor briefing earlier this year where competitors are trying to block and stop Next Science gaining share was a huge accolade the product which is now coming through.
growth results will speak to the success or not.
Ann: Appendix 3Z - Judith Mitchell, page-4
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
-0.015(5.66%) |
Mkt cap ! $77.29M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 27.5¢ | 25.0¢ | $26.91K | 104.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 32963 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 25742 | 5 |
View Market Depth
| Last trade - 13.09pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
25.0¢ |
Change
-0.015 ( 5.66 %) |
||||
| Open | High | Low | Volume | ||
| 27.5¢ | 27.5¢ | 25.0¢ | 10691 | ||
| Last updated 13.09pm 29/05/2024 ? | |||||
| NXS (ASX) Chart |